Page last updated: 2024-10-31

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Brain Neoplasms

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with Brain Neoplasms in 1 studies

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide: calmodulin antagonist; structure given in first source
N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide : A sulfonamide that is 5-chloronaphthalene-2-sulfonamide in which one of the hydrogens of the nitrogen atom is substituted by a 4-aminobutyl group.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiong, DD1
Xu, WQ1
He, RQ1
Dang, YW1
Chen, G1
Luo, DZ1

Other Studies

1 other study available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Brain Neoplasms

ArticleYear
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Oncology reports, 2019, Volume: 41, Issue:4

    Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefit

2019